Get the Stockscreener App
99.39
0.42%
-0.44
Lemaitre Vascular Inc stock is traded at $99.39, with a volume of 93,052.
It is down -0.42% in the last 24 hours and up +7.18% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
See More
Previous Close:
$99.83
Open:
$99.83
24h Volume:
93,052
Relative Volume:
0.60
Market Cap:
$2.24B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
54.31
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+2.56%
1M Performance:
+7.18%
6M Performance:
+23.80%
1Y Performance:
+67.71%
1-Day Range:
$99.16
$101.74
1-Week Range:
$93.28
$101.74
52-Week Range:
$58.66
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
99.32 | 2.24B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
586.03 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.00 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
90.10 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.00 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
321.21 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
(LMAT) Proactive Strategies - Stock Traders Daily
Stentless Bioprostheses Market Detailed In New Research Report - openPR
Conestoga Capital Advisors LLC Cuts Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
BlackRock, Inc. Increases Stake in LeMaitre Vascular Inc. - GuruFocus.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Holdings Raised by Copeland Capital Management LLC - MarketBeat
Pacer Advisors Inc. Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Short Interest Update - MarketBeat
Ausbil Investment Management Ltd Decreases Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
When Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT)? - Simply Wall St
Baldwin Wealth Partners LLC MA Sells 5,032 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 - GlobeNewswire
Winnebago Industries (WGO-N) QuotePress Release - The Globe and Mail
General Motors Company (GM-N) QuotePress Release - The Globe and Mail
LeMaitre Vascular Sets Q4 2024 Earnings Call for February 27 - StockTitan
Copeland Capital Management, LLC Reduces Stake in LeMaitre Vascular Inc - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Has More To Do To Multiply In Value Going Forward - Yahoo Finance
Research Analysts Set Expectations for LMAT FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on LMAT FY2025 Earnings - MarketBeat
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Target Price at $94.57 - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
(LMAT) Trading Signals - Stock Traders Daily
LeMaitre Vascular: Losing Steam (NASDAQ:LMAT) - Seeking Alpha
JPMorgan Chase & Co. Sells 27,324 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
JPMorgan Chase & Co. Decreases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Conestoga Capital Advisors, LLC Reduces Stake in LeMaitre Vascul - GuruFocus.com
Sanctuary Advisors LLC Makes New $181,000 Investment in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Increased by Franklin Resources Inc. - Defense World
Jane Street Group LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Jane Street Group LLC - MarketBeat
(LMAT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
Barclays PLC Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Barclays PLC - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Geode Capital Management LLC Acquires 23,443 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Average PT from Brokerages - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by HighTower Advisors LLC - Defense World
LeMaitre Vascular prices $150M convertible senior notes - MSN
LeMaitre Vascular Prices $150 Million Convertible Senior Notes - Defense World
LeMaitre Vascular's SWOT analysis: niche market leader faces valuation scrutiny - Investing.com
December 2025 Options Now Available For LeMaitre Vascular (LMAT) - Nasdaq
State Street Corp Buys 28,525 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lemaitre Vascular Inc Stock (LMAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Roberts David B | President and Director |
Dec 20 '24 |
Option Exercise |
0.00 |
17 |
0 |
14,657 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 20 '24 |
Option Exercise |
0.00 |
17 |
0 |
9,248 |
| Kamke Trent G | Senior V. P., Operations |
Dec 20 '24 |
Option Exercise |
0.00 |
9 |
0 |
5,129 |
| Jasinski Lawrence J | Director |
Dec 12 '24 |
Option Exercise |
0.00 |
6 |
0 |
5,544 |
| Jasinski Lawrence J | Director |
Dec 11 '24 |
Option Exercise |
0.00 |
6 |
0 |
5,538 |
| Roberts David B | President and Director |
Dec 12 '24 |
Option Exercise |
0.00 |
22 |
0 |
15,034 |
| Roberts David B | President and Director |
Dec 11 '24 |
Option Exercise |
0.00 |
18 |
0 |
15,208 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 12 '24 |
Option Exercise |
0.00 |
22 |
0 |
9,827 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 11 '24 |
Option Exercise |
0.00 |
18 |
0 |
10,099 |
| O'Connor John James | Director |
Dec 12 '24 |
Option Exercise |
0.00 |
6 |
0 |
57,096 |
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):